BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2021 9:35:02 AM | Browse: 880 | Download: 1684
 |
Received |
|
2021-03-14 23:42 |
|
Peer-Review Started |
|
2021-03-15 00:52 |
|
First Decision by Editorial Office Director |
|
2021-06-05 01:44 |
|
Return for Revision |
|
2021-06-05 01:44 |
|
Revised |
|
2021-06-15 21:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-08-26 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-08-27 09:42 |
|
Articles in Press |
|
2021-08-27 09:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-17 03:58 |
|
Publish the Manuscript Online |
|
2021-09-18 09:35 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
Mesenchymal stem cells and COVID-19: What they do and what they can do
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ejlal Abu-El-Rub, Ramada R Khasawneh, Fatimah Almahasneh, Zaid Altaany, Nesreen Bataineh, Hana Zegallai and Saravanan Sekaran |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ejlal Abu-El-Rub, PharmD, PhD, Assistant Professor, Department of Physiology and Pathophysiology, Yarmouk University, Shafiq Irshidat st, Irbid 21163, Jordan. ejlal.abuelrub@yu.edu.jo |
| Key Words |
SARS-CoV-2; COVID-19; Mesenchymal stem cells; Inflammation; Acute respiratory distress syndrome; Pulmonary fibrosis; Pneumonia; Renal injury; Cardiovascular diseases; Regeneration; Anti-inflammatory |
| Core Tip |
Coronavirus disease 2019 (COVID-19) pandemic continues its rampant spread as more vengeant strains emerged in many countries. Severe cases of COVID-19 have been complicated by respiratory failure and multiple organ dysfunction with high mortality rate. Mesenchymal stem cells regenerative and anti-inflammatory abilities can be an innovative approach in repairing the damaged organs and improve the survival rate for critically ill COVID-19 patients. |
| Publish Date |
2021-09-18 09:35 |
| Citation |
Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i9/1318.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i9.1318 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
